Neda Anastassova
Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Precision Design of Single-Atom Catalysts for High-Performance Biosensors.
Journal: Chemical record (New York, N.Y.)
Published: January 12, 2026
Myocardial ischemia-reperfusion therapies based on lipase@CeO2 nanomotors that target and permeate the myocardium and activate the PPARα pathway.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 21, 2025
Exploring the Potential of Indole-3-acetic Acid Arylhydrazone Hybrids for Parkinson's Disease Treatment: A Comprehensive Evaluation of Neuroprotective, MAOB Inhibitory, and Antioxidant Properties.
Journal: ACS chemical neuroscience
Published: March 11, 2025
Behavioral and Biochemical Effects of an Arylhydrazone Derivative of 5-Methoxyindole-2-Carboxylic Acid in a Scopolamine-Induced Model of Alzheimer's Type Dementia in Rats.
Journal: Molecules (Basel, Switzerland)
Published: October 31, 2024
Photothermal and enhanced chemodynamic reinforced anti-tumor therapy based on PDA@POM nanocomposites.
Journal: Journal of colloid and interface science
Published: June 12, 2024
Radical Scavenging Mechanisms of 1-Arylhydrazone Benzimidazole Hybrids with Neuroprotective Activity.
Journal: The journal of physical chemistry. B
Published: May 10, 2023
New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors.
Journal: Antioxidants (Basel, Switzerland)
Published: February 19, 2023
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: March 15, 2022
Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.
Journal: Neural regeneration research
Published: April 05, 2021
Spectroscopic and in silico study on the conversion of N,N'-disubstituted hydrazone derivatives of 5-nitrobenzimidazole-2-thione into anion and radical anion products: Implications in hepatotoxicity.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: February 09, 2020
New benzimidazole-aldehyde hybrids as neuroprotectors with hypochlorite and superoxide radical-scavenging activity.
Journal: Pharmacological reports : PR
Published: July 17, 2019
Benzimidazoles as novel deoxyribonuclease I inhibitors.
Journal: Journal of cellular biochemistry
Published: December 31, 2017
Last Updated: 09/26/2026